Enovix Corp current report, 22 April 2021

Filing Summary

Business Context and Reporting Period

This Form 8-K was filed by Rodgers Silicon Valley Acquisition Corp., the SPAC associated with Enovix Corp., on April 22, 2021, with the report signed April 27, 2021. The filing addresses accounting for warrants issued in the company’s December 2020 initial public offering and affects the audited balance sheet as of December 4, 2020 and the fiscal year ended December 31, 2020.

Financial and Accounting Impact

  • The company had classified 11,500,000 public warrants and 6,000,000 private placement warrants as equity.
  • Following SEC guidance issued April 12, 2021, the warrants will be reclassified as derivative liabilities measured at fair value, with changes in fair value recognized in earnings.
  • The filing does not provide the revised warrant liability valuation or the resulting effect on net income, total liabilities, assets, or shareholders’ equity.
  • The company stated that the accounting change will not affect previously reported operating expenses, cash flows, or cash.
  • The filing does not provide revenue, profit, margin, debt, liquidity, or operating cash flow metrics.

Material Changes Versus Prior Reporting

The company concluded that its previously issued financial statements for the IPO balance sheet and fiscal year ended December 31, 2020 should no longer be relied upon. It will restate its Form 10-K for 2020 and the December 4, 2020 balance sheet previously filed as an exhibit to an earlier Form 8-K.

The restatement is limited to the accounting analysis and classification of the warrants under ASC 815-40, Contracts in Entity’s Own Equity.

Guidance, Risks, and Controls

  • Management determined that disclosure controls and procedures were not effective for the affected periods with respect to warrant classification.
  • The filing does not provide financial guidance or an expected filing date for the amended Form 10-K.
  • Future earnings may be affected by changes in the fair value of the warrant derivative liabilities, although the filing states that cash and cash flows are unaffected.
  • The filing states that the matter was discussed with the company’s independent accountant.

Investor Verification Items

  • Verify the amended Form 10-K and restated December 4, 2020 balance sheet.
  • Verify the fair value assigned to the public and private placement warrant liabilities and the cumulative income-statement impact.
  • Assess the effect of the restatement on total liabilities, shareholders’ equity, loss per share, and applicable financial statement disclosures.
  • Review subsequent filings for remediation of the ineffective disclosure controls and any additional accounting or reporting issues.